These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12885268)

  • 1. ADAM33: a novel therapeutic target for asthma.
    Powell RM; Hamilton LM; Holgate ST; Davies DE; Holloway JW
    Expert Opin Ther Targets; 2003 Aug; 7(4):485-94. PubMed ID: 12885268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADAM8: a new therapeutic target for asthma.
    Knolle MD; Owen CA
    Expert Opin Ther Targets; 2009 May; 13(5):523-40. PubMed ID: 19397475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness.
    Van Eerdewegh P; Little RD; Dupuis J; Del Mastro RG; Falls K; Simon J; Torrey D; Pandit S; McKenny J; Braunschweiger K; Walsh A; Liu Z; Hayward B; Folz C; Manning SP; Bawa A; Saracino L; Thackston M; Benchekroun Y; Capparell N; Wang M; Adair R; Feng Y; Dubois J; FitzGerald MG; Huang H; Gibson R; Allen KM; Pedan A; Danzig MR; Umland SP; Egan RW; Cuss FM; Rorke S; Clough JB; Holloway JW; Holgate ST; Keith TP
    Nature; 2002 Jul; 418(6896):426-30. PubMed ID: 12110844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble guanylate cyclase as an alternative target for bronchodilator therapy in asthma.
    Ghosh A; Koziol-White CJ; Asosingh K; Cheng G; Ruple L; Groneberg D; Friebe A; Comhair SA; Stasch JP; Panettieri RA; Aronica MA; Erzurum SC; Stuehr DJ
    Proc Natl Acad Sci U S A; 2016 Apr; 113(17):E2355-62. PubMed ID: 27071111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADAM metallopeptidase domain 33 (ADAM33): identification and role in airways disease.
    Holgate ST
    Drug News Perspect; 2010; 23(6):381-7. PubMed ID: 20697605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoke exposure interacts with ADAM33 polymorphisms in the development of lung function and hyperresponsiveness.
    Reijmerink NE; Kerkhof M; Koppelman GH; Gerritsen J; de Jongste JC; Smit HA; Brunekreef B; Postma DS
    Allergy; 2009 Jun; 64(6):898-904. PubMed ID: 19236319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADAM33's Role in Asthma Pathogenesis: An Overview.
    Sleziak J; Gawor A; Błażejewska M; Antosz K; Gomułka K
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progress in study of ADAM33 gene].
    Su ZG; Wen FQ; Feng YL
    Yi Chuan; 2005 Jul; 27(4):636-40. PubMed ID: 16120592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchial hyperresponsiveness in adolescents with long-term asthma remission: importance of a Family history of bronchial hyperresponsiveness.
    Koh YY; Kang EK; Kang H; Yoo Y; Park Y; Kim CK
    Chest; 2003 Sep; 124(3):819-25. PubMed ID: 12970003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular interaction network and pathway studies of ADAM33 potentially relevant to asthma.
    Vishweswaraiah S; Veerappa AM; Mahesh PA; Jayaraju BS; Krishnarao CS; Ramachandra NB
    Ann Allergy Asthma Immunol; 2014 Oct; 113(4):418-24.e1. PubMed ID: 25155083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the pathophysiology of severe asthma to generate new therapeutic opportunities.
    Holgate ST; Holloway J; Wilson S; Howarth PH; Haitchi HM; Babu S; Davies DE
    J Allergy Clin Immunol; 2006 Mar; 117(3):496-506; quiz 507. PubMed ID: 16522446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoids ameliorate antigen-induced bronchial smooth muscle hyperresponsiveness by inhibiting upregulation of RhoA in rats.
    Chiba Y; Goto K; Hirahara M; Sakai H; Misawa M
    J Pharmacol Sci; 2008 Apr; 106(4):615-25. PubMed ID: 18391481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Airway irritability--a burning issue?
    Spina D; Page C
    Curr Opin Pharmacol; 2009 Aug; 9(4):530-4. PubMed ID: 19625215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrins: therapeutic targets in airway hyperresponsiveness and remodelling?
    Wright DB; Meurs H; Dekkers BG
    Trends Pharmacol Sci; 2014 Nov; 35(11):567-74. PubMed ID: 25441775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel polymorphisms in the Adam33 gene.
    Chae SC; Yoon KH; Chung HT
    J Hum Genet; 2003; 48(5):278-281. PubMed ID: 12768445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of ADAM33 in the pathogenesis of asthma.
    Cakebread JA; Haitchi HM; Holloway JW; Powell RM; Keith T; Davies DE; Holgate ST
    Springer Semin Immunopathol; 2004 Feb; 25(3-4):361-75. PubMed ID: 14999429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADAM33: a newly identified protease involved in airway remodelling.
    Holgate ST; Davies DE; Powell RM; Holloway JW
    Pulm Pharmacol Ther; 2006; 19(1):3-11. PubMed ID: 15953744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asthma therapy: how far have we come, why did we fail and where should we go next?
    Janssen LJ
    Eur Respir J; 2009 Jan; 33(1):11-20. PubMed ID: 19118224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging airway smooth muscle targets to treat asthma.
    Siddiqui S; Redhu NS; Ojo OO; Liu B; Irechukwu N; Billington C; Janssen L; Moir LM
    Pulm Pharmacol Ther; 2013 Feb; 26(1):132-44. PubMed ID: 22981423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel peptide ADAM8 inhibitor attenuates bronchial hyperresponsiveness and Th2 cytokine mediated inflammation of murine asthmatic models.
    Chen J; Deng L; Dreymüller D; Jiang X; Long J; Duan Y; Wang Y; Luo M; Lin F; Mao L; Müller B; Koller G; Bartsch JW
    Sci Rep; 2016 Jul; 6():30451. PubMed ID: 27458083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.